Zydus,

Zydus, Daewoong Pharmaceutical collaborate for development and commercialisation of Leuprolide Acetate for Depot Suspension

Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical on Monday announced that they have entered into an exclusive licensing agreement to co-develop and commercialize Leuprolide Acetate for Depot Suspension (RLD: Lupron Depot®, AbbVie) in six dosage strengths for the United States market.

Zydus, Daewoong Pharmaceutical collaborate for development and commercialisation of Leuprolide Acetate for Depot Suspension Read More

84% of manufacturing employees acknowledge two separate cultures in their company: Survey by UKG

Amidst the dynamic contours of the Indian manufacturing sector, a notable majority of organisations are taking proactive strides to embrace flexibility, ushering in a new era of improved working conditions for their frontline workforce.

84% of manufacturing employees acknowledge two separate cultures in their company: Survey by UKG Read More